我国创新药物研发的困惑与展望

面对我国创新药物研究的现状与发达国家的差距，分析了造成这种差距的主要原因是长期的计划经济使我国的制药企业不能尽快成为创新药物研究的主体；缺少敢于构建创新药物研究平台的企业家和优良的市场环境；科学家和企业家的磨合问题；政府的职能转换。根据以上原因提出了缩短我国创新药物研发差距的措施：体制创新；企业要坚定不移的构建创新药物研究平台；转变政府职能，优化市场环境；制药企业要强强联合。

Perplexity and prospect of newly researched and developed drug in China

The study analyzes the major factors which h ave led to the differences between the current situation of drug research and de velopment in China and that in the developed countries: Long-time-existing pla nned economy has prevented Chinese medical enterprises from rapidly becoming the principal part in drug research and development; there is a lack of the entrepr eneurs who can establish the drug research and development systems and availa ble market environment; scientists and entrepreneurs have difficulty in cooperat ing well; the reorientation about the government functions leaves much to be desired Based on above factors, this study has developed related measureme nt s to reduce the differences, such as conducting the structural innovation; esta blishing the drug research and developments systems unalterably; rearranging the functions of the governments and optimizing the market environment; strengthen ing the cooperation among the excellent pharmceutical enterprises in China